Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.
D000328:Adult; D003168:Complement Fixation Tests; D005260:Female; D005334:Fever / Q000209:etiology; D005455:Fluorescent Antibody Technique; D006562:Herpes Zoster / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007165:Immunosuppression Therapy; D007372:Interferons / Q000008:administration & dosage* / Q000097:blood / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D007700:Kinetics; D007962:Leukocytes; D008223:Lymphoma / Q000150:complications; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014762:Viral Interference
D007372:Interferons